Medical Device Markets for Near Field Communication

The Connected Patient

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Connected devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants.

What You Will Learn:

• What medical devices incorporate near field communication technology, how do they work and what new capabilities do they offer to patients and their HCPs?

• What benefits do NFC enabled drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?

• What therapeutic areas are the current focus of NFC enabled devices?

• Who are the companies behind the push to integrate communication capabilities into injection devices? What are their development activities and corporate alliances and affiliations

• What is the importance of pharma-device alliances and design partnerships on medical device commercialization and market access?

• What does the current market for connected medical devices look like?

• What are the key market drivers for the growth of NFC enabled medical devices?